Skip to main content
Log in

Arachidonic acid cascade and platelet-activating factor in the network of eye inflammatory mediators: therapeutic implications in uveitis

  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The cellular and biochemical events triggered by uveitis involve a complex array of cells and a heterogeneous network of mediators of intraocular inflammation. Resident cells are activated and inflammatory cells are recruited. Chemical mediators from the arachidonic acid cascade, prostaglandins, hydroxyeicosatetraenoic acids, and leukotrienes, are formed. Several of these metabolites are modulators of cellular functions, but when generated in sustained, excessive amounts, they contribute to enhanced vascular permeability and to the onset of pathophysiological responses. Another very active membrane-derived mediator is plateletactivating factor. This important mediator of immune and inflammatory responses may play a central role in uveitis due to cell priming, since interleukin-1, tumor necrosis factor, and other as yet unidentified mediators are also being generated. The concomitant accumulation of these networks of mediators in various parts of the uveal tract leads to spreading of the intraocular inflammatory response and cellular damage. At both early and late stages of uveitis, the generation of free radicals is also a major contributor to the impairment of function. Free radicals are generated in two distinct sites: in the oxidative burst of recruited white cells and in free radical formation and lipid peroxidation in resident cells. The identification of the cellular events that lead to the accumulation of networks of mediators of inflammation and their effects has important therapeutic implications in uveitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

EAU:

experimental autoimmune uveitis

5-HETE, 12-HETE, 15-HETE:

5-,12-,15-hydroxyeicosatetraenoic acid

IL-1:

interleukin-1

LT:

leukotriene

PAF:

platelet-activating factor

PG:

prostaglandin

PMN:

polymorphonuclear leukocyte

TNF:

tumor necrosis factor

References

  1. Martenet AC, Bischoff PM, Grob PJ, Fierz W. Immune complexes and uveitis. In: Silverstein AM, O'Connor GR, eds. Immunology and Immunopathology of the Eye. Masson Publishing USA Inc, New York, 1979: 55–57.

    Google Scholar 

  2. Gautheron PD, Coulbault L, Sugrue MF. A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L-652,731. J Pharm Pharmacol 1987, 39: 857–859.

    Google Scholar 

  3. Ruedemann AD. Ocular manifestation of allergy. In: Thomas JW, ed. Allergy in Clinical Practice, Philadephia: JP Lippincott Co, 1961: 256–274.

    Google Scholar 

  4. O'Connor GR. Uveitis of immunological origin: Clinical syndromes. Trans Pac Coast Oto-Ophthalmol Soc 1976, 57: 213–221.

    Google Scholar 

  5. Belfort Jr R. Imunologia das doenças oculares. In: Jobim LFJ, Mendes NF, Lima AD, eds. Imunologia Clinica. Rio de Janeiro, Guanabara Koogan, 1980: 105–116.

    Google Scholar 

  6. Marak Jr GE, Font RL, Alepa FP. Experimental lensinduced granulomatous endophthalmitis. Mod Probl Ophthalmol 1976, 16: 75–79.

    Google Scholar 

  7. Williams BD, Lehner T. Immune complexes in Behçet's syndrome and recurrent oral ulceration. Br Med J 1977, 1: 1387–1389.

    Google Scholar 

  8. Wacker WB, Rao NA, Marak Jr GE. Experimental sympathetic ophthalmia. In: Silverstein AM, O'Connor GR, eds, Immunology and Immunopathology of the Eye. Masson Publishing USA Inc, New York, 1979: 121–126.

    Google Scholar 

  9. Easty DL, Carter C, Funk A. Systemic immunity in herpetic keratitis. Br J Ophthalmol 1981, 65: 82–88.

    Google Scholar 

  10. Abreu MT, Hirata PS, Belfort Jr R, Domingues Neto S. Uveítis em Sao Paulo -estudo epidemiológico, clínico e terapêutico. Pal Oftal Panam 1980, 4: 21–30.

    Google Scholar 

  11. Arffa RC, Schlaegel TF. Chorioretinal scars in Fuch's heterochromic cyclitis. Arch Ophthalmol 1984, 102: 1153–1155.

    Google Scholar 

  12. Dernouchamps JP, Vaerman JP, Michiels J, Masson PL. Immune complexes in the aqueous humor and serum. Am J Ophthalmol 1977, 84: 24–31.

    Google Scholar 

  13. Lowder CY, Lyon H, Char DH. C3b receptors in the human uveal tract. Suppl Invest Ophthalmol Vis Sci 1983, 24: 38.

    Google Scholar 

  14. Nussenblatt RB, Kuwabara T, De Monasterio FM, Wacker WB. S-antigen uveitis in primates. A new model for human disease. Arch Ophthalmol 1981, 99: 1090–1092.

    Google Scholar 

  15. Nussenblatt RB, Gery I, Ballintine EJ, Wacker WB. Cellular immune responsiveness of uveitis patients to retinal S-antigen. Am J Ophthalmol 1980, 89: 173–179.

    Google Scholar 

  16. Rao NA, Wacker WB, Marak Jr GE. Experimental allergic uveitis. Clinicopathologic features associated with varying doses of S-antigen. Arch Ophthalmol 1979, 97: 1954–1958.

    Google Scholar 

  17. Gery I, Robison Jr WG, Shichi H, El Saied M, Mochizuki M, Nussenblatt RB, Williams RM. Differences in susceptibility to experimental autoimmune uveitis among rats of various strains. In: O'Connor GR, Chandler JW, eds. Advances in Immunology and Immunopathology of the Eye. New York: Massen, 1985: 242–245.

    Google Scholar 

  18. Bloch-Michel E. Difficulties in the knowledge of uveitis. In: Proceedings of the First International Symposium on Uveitis. Hanasaari Espoo, Finland, May 16–19, 1984: 14–20.

  19. Faure JP. O modelo experimental da uveorretinite autoimune. In: Oréfice F, Belfort Jr R, eds. Uveítes. Livraria Roca Ltda, 1987: 73–82.

  20. Bazan HEP. The synthesis and effects of eicosanoids in avascular ocular tissues. In: Bito L, ed. Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R. Liss, 1989: 73–84.

    Google Scholar 

  21. Tounesin MG, Worthen GS, Johnston Jr R. Neutrophil emigration, activation, and tissue damage. In: The molecular and cellular biology of wound repair, Clark RAF, Henson PM, eds. Plenum Press, New York, 1988: 149–183.

    Google Scholar 

  22. Hogan MJ, Wood S, Godfrey WA. Aqueous humor cytology in uveitis. Arch Ophthalmol 1973, 89: 217–220.

    Google Scholar 

  23. Verrey F. Clinique del'humeur agueuse. Neuchâtel, Delachaux et Niestlé, 1954.

  24. Belfort Jr R, Moura NC, Mendes NF. T and B lymphocytes in the aqueous humor of patients with uveitis. Arch Ophthalmol 1982, 100: 465–467.

    Google Scholar 

  25. Abreu MT, Belfort Jr R, Matheus PC, Santos LMB, Scheinberg MA. T-lymphocyte subsets in the aqueous humor and peripheral blood of patients with acute untreated uveitis. Am J Ophthalmol 1984, 98: 62–65.

    Google Scholar 

  26. Starr MS. Further studies on the effect of prostaglandin on intraocular pressure in the rabbit. Exp Eye Res 1971, 11: 170–177.

    Google Scholar 

  27. Eakins KE, Whitelocker RAF, Perkins ES. Release of prostaglandins in ocular inflammation in the rabbit. Nature New Biol 1972, 239: 248–249.

    Google Scholar 

  28. Kelly RGM, Starr MS. Effects of prostaglandins and a prostaglandin antagonist on intraocular pressure and protein in the monkey eye. Can J Ophthalmol 1971, 6: 205–211.

    Google Scholar 

  29. Eakins KE, Whitelocker RAF, Bennett A, Martenet AC. Prostaglandin-like activity in ocular inflammation. Br Med J 1972, 3: 452–453.

    Google Scholar 

  30. Masuda K, Izawa Y, Mishima S. Prostaglandins and uveitis: A preliminary report. Jpn J Ophthalmol 1973, 17: 166–170.

    Google Scholar 

  31. Kulkarni PS, Rodrigues AV, Srinivasan BD. Human anterior uvea synthesizes lipoxygenase products from arachidonic acid. Invest Ophthalmol Vis Sci 1984, 25: 201–203.

    Google Scholar 

  32. Rola-Pleszczynski M. Differential effects of leukotriene B4 on T4 + and T8 + lymphocyte phenotype and immunoregulatory functions. J Immunol 1985, 135: 1357–1360.

    Google Scholar 

  33. Kaplan HJ, Aaberc TM, Keller RH. Recurrent clinical uveitis. Cell surface markers on vitreous lymphocytes. Arch Ophthalmol 1982, 100: 585.

    Google Scholar 

  34. Keppler A, Orning L, Bernström K, Hammarström S. Endogenous leukotriene D4 formation during anaphylactic shock in the guinea pig. Proc Nat Acad Sci USA 1987, 84: 5903–5907.

    Google Scholar 

  35. Mahlberg K, Uusitalo R, Uusitalo H, Palkema A, Tallberg T. Phospholipase A2, leukotriene C4 and prostaglandin E2 levels in aqueous humor of guinea pigs with experimental S-antigen-induced autoimmune uveitis. Curr Eye Res 1987, 6: 321–335.

    Google Scholar 

  36. Chiou LY, Chiou GCY. Prevention of ocular inflammation by lipoxygenase inhibitors. (Abstract) Suppl Invest Ophthalmol Vis Sci 1989: 247.

  37. Kulkarni PS, Srinivasan BD. Synthesis of slow-reacting substance-like activity in rabbit conjunctiva and anterior uvea. Invest Ophthalmol Vis Sci 1983; 24: 1079–1085.

    Google Scholar 

  38. Parker JA, Goetzl EJ, Friedlaender MH. Leukotrienes in the aqueous humor of patients with uveitis. Arch Ophthalmol 1986, 104: 722–724.

    Google Scholar 

  39. Miyanaga Y, Kin K, Takano M, Shinriki Y. Studies on leukotriene B4 in the experimental and the clinical uveitis. Abstract of International Symposium on Prostaglandins and Related Compounds in Ophthalmology, 1986: 27.

  40. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987, 39: 97–145.

    Google Scholar 

  41. Bazan HEP, Reddy STK, Woodland JM, Bazan NG. The accumulation of platelet-activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. Biochem Biophys Res Commun 1987, 149: 915–920.

    Google Scholar 

  42. Bazan HEP, Reddy STK. Production of platelet-activating factor (PAF) in the cornea after injury. Suppl Invest Ophthalmol Vis Sci 1989, 30: 404.

    Google Scholar 

  43. Vercellotti GM, Huh PW, Yin HQ, Nelson RD, Jacobs HS. Enhancement of PMN-mediated endothelial damage by platelet-activating factor (PAF): PAF primes PMN responses to activating stimuli. Clin Res 1986, 34: 917.

    Google Scholar 

  44. Verbey NL, Van Delft JL, Van Hoeringen NJ, Braquet P. Platelet-activating factor and laser trauma of the iris. Invest Ophthalmol Vis Sci 1989, 30: 1101–1103.

    Google Scholar 

  45. Lin N, Braquet P, Bazan NG, Bazan HEP. Platelet-activating factor antagonists reduce the inflammatory response in endotoxin-induced keratitis and uveitis. XXVI International Congress of Ophthalmology, March 18–24, 1990, Singapore.

  46. Howes EL, Cruse VK, Kwok MT. Mononuclear cells in the corneal response to endotoxin. Invest Ophthalmol Vis Sci 1982, 22: 494–501.

    Google Scholar 

  47. Sery TW, Petrillo R. Superoxide anion radical as an indirect mediator in ocular inflammatory disease. Curr Eye Res 1984, 3: 243–252.

    Google Scholar 

  48. Rao NA, Sevanian A, Fernandez MAS, Romero JL, Faure J-P, de Kozak Y, Till GO, Marak Jr GE. Role of oxygen radicals in experimental allergic uveitis. Invest Ophthalmol Vis Sci 1987, 28: 886–892.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bazan, N.G., de Abreu, M.T., Bazan, H.E.P. et al. Arachidonic acid cascade and platelet-activating factor in the network of eye inflammatory mediators: therapeutic implications in uveitis. Int Ophthalmol 14, 335–344 (1990). https://doi.org/10.1007/BF00163553

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00163553

Key words

Navigation